0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-11H675
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Flu Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Flu Vaccine Market Research Report 2024

Code: QYRE-Auto-11H675
Report
January 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Flu Vaccine Market Size

The global Flu Vaccine market was valued at US$ 5505 million in 2023 and is anticipated to reach US$ 7673.2 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Flu Vaccine Market

Flu Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.

Report Scope

The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Flu Vaccine Market Report

Report Metric Details
Report Name Flu Vaccine Market
Accounted market size in 2023 US$ 5505 in million
Forecasted market size in 2030 US$ 7673.2 million
CAGR 4.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Segment by Application
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Flu Vaccine Market growing?

Ans: The Flu Vaccine Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Flu Vaccine Market size in 2030?

Ans: The Flu Vaccine Market size in 2030 will be US$ 7673.2 million.

What is the market share of major companies in Flu Vaccine Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Flu Vaccine Market share by type?

Ans: In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%.

Who are the main players in the Flu Vaccine Market report?

Ans: The main players in the Flu Vaccine Market are Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO

What are the Application segmentation covered in the Flu Vaccine Market report?

Ans: The Applications covered in the Flu Vaccine Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Flu Vaccine Market report?

Ans: The Types covered in the Flu Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Flu Vaccine Market Overview
1.1 Product Overview and Scope of Flu Vaccine
1.2 Flu Vaccine Segment by Type
1.2.1 Global Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Segment by Application
1.3.1 Global Flu Vaccine Market Value by Application: (2024-2030)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Flu Vaccine Revenue 2019-2030
1.4.2 Global Flu Vaccine Sales 2019-2030
1.4.3 Global Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Flu Vaccine Market Competition by Manufacturers
2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flu Vaccine, Product Type & Application
2.7 Flu Vaccine Market Competitive Situation and Trends
2.7.1 Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flu Vaccine Players Market Share by Revenue
2.7.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Flu Vaccine Global Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global Flu Vaccine Sales by Region: 2025-2030
3.3 Global Flu Vaccine Global Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global Flu Vaccine Revenue by Region: 2025-2030
3.4 North America Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America Flu Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Flu Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Flu Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Flu Vaccine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hulan Bio Flu Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Flu Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CCBIO Flu Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu Vaccine Industry Chain Analysis
7.2 Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu Vaccine Production Mode & Process
7.4 Flu Vaccine Sales and Marketing
7.4.1 Flu Vaccine Sales Channels
7.4.2 Flu Vaccine Distributors
7.5 Flu Vaccine Customers
8 Flu Vaccine Market Dynamics
8.1 Flu Vaccine Industry Trends
8.2 Flu Vaccine Market Drivers
8.3 Flu Vaccine Market Challenges
8.4 Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Flu Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Flu Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Flu Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Flu Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Flu Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Flu Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 18. Global Flu Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Flu Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 20. Global Flu Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Flu Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Flu Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Flu Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 27. North America Flu Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 28. North America Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Flu Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 32. Europe Flu Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 33. Europe Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Flu Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 37. Asia Pacific Flu Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 38. Asia Pacific Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Flu Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 42. Latin America Flu Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 43. Latin America Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Flu Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 47. Middle East & Africa Flu Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 48. Middle East & Africa Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Flu Vaccine Sales (M Doses) by Type (2019-2024)
    Table 51. Global Flu Vaccine Sales (M Doses) by Type (2025-2030)
    Table 52. Global Flu Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Flu Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Flu Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Flu Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Flu Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Flu Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Flu Vaccine Price (US$/Dose) by Type (2019-2024)
    Table 59. Global Flu Vaccine Price (US$/Dose) by Type (2025-2030)
    Table 60. Global Flu Vaccine Sales (M Doses) by Application (2019-2024)
    Table 61. Global Flu Vaccine Sales (M Doses) by Application (2025-2030)
    Table 62. Global Flu Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Flu Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Flu Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Flu Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Flu Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Flu Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Flu Vaccine Price (US$/Dose) by Application (2019-2024)
    Table 69. Global Flu Vaccine Price (US$/Dose) by Application (2025-2030)
    Table 70. Sanofi Pasteur Corporation Information
    Table 71. Sanofi Pasteur Description and Business Overview
    Table 72. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 73. Sanofi Pasteur Flu Vaccine Product
    Table 74. Sanofi Pasteur Recent Developments/Updates
    Table 75. CSL Corporation Information
    Table 76. CSL Description and Business Overview
    Table 77. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 78. CSL Flu Vaccine Product
    Table 79. CSL Recent Developments/Updates
    Table 80. GSK Corporation Information
    Table 81. GSK Description and Business Overview
    Table 82. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 83. GSK Flu Vaccine Product
    Table 84. GSK Recent Developments/Updates
    Table 85. Mylan Corporation Information
    Table 86. Mylan Description and Business Overview
    Table 87. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 88. Mylan Flu Vaccine Product
    Table 89. Mylan Recent Developments/Updates
    Table 90. Hulan Bio Corporation Information
    Table 91. Hulan Bio Description and Business Overview
    Table 92. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 93. Hulan Bio Flu Vaccine Product
    Table 94. Hulan Bio Recent Developments/Updates
    Table 95. AstraZeneca Corporation Information
    Table 96. AstraZeneca Description and Business Overview
    Table 97. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 98. AstraZeneca Flu Vaccine Product
    Table 99. AstraZeneca Recent Developments/Updates
    Table 100. CCBIO Corporation Information
    Table 101. CCBIO Description and Business Overview
    Table 102. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 103. CCBIO Flu Vaccine Product
    Table 104. CCBIO Recent Developments/Updates
    Table 105. Key Raw Materials Lists
    Table 106. Raw Materials Key Suppliers Lists
    Table 107. Flu Vaccine Distributors List
    Table 108. Flu Vaccine Customers List
    Table 109. Flu Vaccine Market Trends
    Table 110. Flu Vaccine Market Drivers
    Table 111. Flu Vaccine Market Challenges
    Table 112. Flu Vaccine Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Flu Vaccine
    Figure 2. Global Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Flu Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Trivalent Influenza Vaccine Product Picture
    Figure 5. Quadrivalent Influenza Vaccine Product Picture
    Figure 6. Global Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Flu Vaccine Market Share by Application in 2023 & 2030
    Figure 8. For Children (6 months to 3 years)
    Figure 9. For Adults and Children over 3 years
    Figure 10. Global Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Flu Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Flu Vaccine Sales (2019-2030) & (M Doses)
    Figure 13. Global Flu Vaccine Average Price (US$/Dose) & (2019-2030)
    Figure 14. Flu Vaccine Report Years Considered
    Figure 15. Flu Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Flu Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Flu Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Flu Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Flu Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Flu Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Flu Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Flu Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Flu Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Flu Vaccine Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Flu Vaccine Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Flu Vaccine Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Flu Vaccine Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Flu Vaccine by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Flu Vaccine by Type (2019-2030)
    Figure 54. Global Flu Vaccine Price (US$/Dose) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Flu Vaccine by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Flu Vaccine by Application (2019-2030)
    Figure 57. Global Flu Vaccine Price (US$/Dose) by Application (2019-2030)
    Figure 58. Flu Vaccine Value Chain
    Figure 59. Flu Vaccine Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS